A Biogen facility in Cambridge, the US. Picture: REUTERS/BRIAN SNYDER
Choosing a course of action is shaping up as one of the most consequential drug-approval decisions that the FDA has made in years. Biogen has said it plans to submit aducanumab to the agency in early 2020. At stake are the fates millions of Alzheimer’s patients, along with billions of dollars in sales and stock-price gains for Biogen and its Japanese partner Eisai.
“They need a tiebreaker,” said Suzanne Craft, an Alzheimer’s researcher at Wake Forest School of Medicine, shortly after the presentation, expressing a widely held sentiment among the attendees. “We all want it to be real, but the evidence is not sufficient to justify declaring this a ready-for-prime-time treatment.
“While we’d love to see a drug benefit millions of people, this remains a subgroup analysis of post-hoc data,” he wrote. “In a normal world, this isn’t sufficient for approval.”
Oh, thought they forgot what the name was....
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IOL - 🏆 46. / 51 Read more »
Trevor Noah and Lasizwe top the list of most watched on YouTube South Africa for 2019Amapiano may have taken South Africa by storm but when it comes to YouTube hits, hip hop artists like Nasty C, Biggy, Cardi B and Lil Nas X dominated. | ThangoSays
Source: SowetanLIVE - 🏆 13. / 63 Read more »
ALWYN VAN DER MERWE: Global equities come out on top in 2019 investingNext year will not be quite as bountiful and valuation will be even more crucial
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: News24 - 🏆 4. / 80 Read more »
Source: IOL - 🏆 46. / 51 Read more »
ALWYN VAN DER MERWE: Global equities come out on top in 2019 investingNext year will not be quite as bountiful and valuation will be even more crucial
Source: BDliveSA - 🏆 12. / 63 Read more »